NVOS 财务： Novo Integrated Sciences Inc AI 分析

主页

股票

NVOS

财务数据

NVOS 财务

Novo Integrated Sciences Inc

416.66%

$0

截至今日：Apr 02, 11:30:38 GMT-4

概述预测收益股息财务数据

关键数据

前收盘价

$0.0006

开盘价

$0.005

当日区间

$0.0031 - $0.005

52周范围

$0.0001 - $0.06

交易量

1.5K

平均成交量

3.4K

股息收益率

每股收益（TTM）

-0.91

市值

$61.1K

什么是 NVOS？

Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

NVOS 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	08/31/2024	08/31/2023	08/31/2022	08/31/2021	08/31/2020
营收	13	13	12	11	9	7
营收同比增长 (YoY)	8%	8%	9%	22%	28.99%	-22%
营收成本	7	7	7	6	5	4
毛利润	5	5	4	4	3	3
销售、一般及管理费用	14	14	13	14	8	7
研发	--	--	--	--	--	--
营业费用	14	14	13	14	8	7
其他非经营性收入 (费用)	-1	-1	0	0	--	0
税前利润	-16	-16	-13	-33	-4	-4
所得税费用	0	0	0	0	0	0
净利润	-16	-16	-13	-32	-4	-4
净利润增长	23%	23%	-59%	700%	0%	--
稀释后流通股数	19.06	18.03	10.16	2.91	2.48	2.3
股份同比变动 (YoY)	28%	77%	249%	17%	8%	6%
每股收益 (摊薄)	-0.84	-0.89	-1.29	-11.28	-1.8	-2.13
每股收益增长率	-5%	-31%	-88%	527%	-15%	1,083%
自由现金流	-5	-5	-2	-6	-1	0
每股自由现金流	--	--	--	--	--	--
毛利率	38.46%	38.46%	33.33%	36.36%	33.33%	42.85%
营业利润率	-61.53%	-61.53%	-66.66%	-81.81%	-44.44%	-57.14%
净利率	-123.07%	-123.07%	-108.33%	-290.9%	-44.44%	-57.14%
自由现金流利润率	-38.46%	-38.46%	-16.66%	-54.54%	-11.11%	0%
EBITDA	-6	-6	-6	-6	-3	-3
EBITDA 利润率	-46.15%	-46.15%	-50%	-54.54%	-33.33%	-42.85%
EBITDA 中的折旧与摊销	2	2	2	3	1	1
EBIT	-8	-8	-8	-9	-4	-4
EBIT 利润率	-61.53%	-61.53%	-66.66%	-81.81%	-44.44%	-57.14%
有效税率	0%	0%	0%	0%	0%	0%

Follow-Up Questions

Novo Integrated Sciences Inc 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Novo Integrated Sciences Inc 的总资产为 $32，净损失为 $-16

NVOS 的关键财务比率是什么？



Novo Integrated Sciences Inc 的流动比率是 1.88，净利 margin 为 -123.07，每股销售为 $0.72。

Novo Integrated Sciences Inc 的收入按细分市场或地理位置如何划分？



Novo Integrated Sciences Inc 最大收入来源是 Healthcare Services，在最近的收益报告中收入为 8,297,530。就地区而言， United States 是 Novo Integrated Sciences Inc 的主要市场，收入为 13,294,357。

Novo Integrated Sciences Inc 是否盈利？



不，根据最新的财务报表，Novo Integrated Sciences Inc 的净损失为 $-16

Novo Integrated Sciences Inc 有负债吗？



是的，Novo Integrated Sciences Inc 的负债为 17

Novo Integrated Sciences Inc 的流通股有多少？



Novo Integrated Sciences Inc 的总流通股为 19.05

Novo Integrated Sciences Inc (NVOS) 财务

NVOS 股价走势图